BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Hummingbird Bioscience to Present Pre-Clinical Data on Novel Biomarkers for HER3-driven Cancers

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announce...

October 08, 2021 | News

Japan to Encourages Breakthrough Cancer Research

Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of the 17th annual JCA Mauvernay Awar...

October 05, 2021 | News

GenScript ProBio and AskGene Enter into a Non-exclusive License of A sdAb Targeting Immune Checkpoint Target

GenScript ProBio grants a non-exclusive global license to AskGene to use GenScript ProBio's sdAb targeting immune checkpoint target for disc...

September 27, 2021 | News

Australia Approved New Therapy to Treat Advanced Small Cell Lung Cancer

Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved to treat second-line metastatic SCLC in Australia in more tha...

September 15, 2021 | News

Taiwan to provide smart access to personalized cancer care

Varian, a Siemens Healthineers company, announced today that China Medical University Hospital in Central Taiwan treated its first patient with E...

September 13, 2021 | News

Elekta to address Indonesia's cancer care gap with direct presence

Elekta (EKTA-B.ST) announced today that is has established permanent legal entity in Indonesia's capital, Jakarta in order to address t...

August 25, 2021 | News

InnoCare Announces First Subject Dosed in Clinical Trial of ICP-332

InnoCare discovered and developed the oral drug candidate ICP-332. As a non-receptor tyrosine kinase, TYK2 is a member of the JAK kinase family, which is a...

August 16, 2021 | News

Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy

Terumo Blood and Cell Technologies (Terumo), a medical device company specializing in a portfolio of technology, software and services for blood...

August 12, 2021 | News

VERAXA Biotech and Indivumed Cooperate on the Development of Precision Oncology Antibody

The targets have been identified by Indivumed’s discovery solution platform nRavel®, only two months after its launch. The antibody development a...

August 10, 2021 | News

Pharmaxis Cancer Drug Decreases Tumour Burden in Pre Clinical Liver Cancer Model

Clinical stage drug development company Pharmaxis Ltd (ASX: PXS) today announced the first public presentation of data from a preclinical study of PXS-5505...

August 06, 2021 | News

Zelgen and 111, Inc. to Develop a New Management Platform for Liver Cancer Patients in China

111, Inc. , a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in&nb...

August 04, 2021 | News

eTheRNA immunotherapies opens office in Hong Kong to support and build on its growing activities in China and broader Asia-Pacific

The Asia-Pacific region is growing in importance in the global healthcare sector and this new subsidiary will serve as a focus for eTheRNA’s increasi...

August 03, 2021 | News

Clarity commences theranostic prostate cancer trial

Clarity's Executive Chairman, Dr Alan Taylor, commented, "The prostate cancer market is a key focus for Clarity and we are very pleased to commence th...

July 29, 2021 | News

Zhongchao To Promote the Equalization of Breast Cancer Diagnosis

Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, pro...

July 28, 2021 | News

Stay Connected